RE:RE:Theralase PDCs are approximately a billion times more potentLAMBO wrote: NOt sure how much the anti-cancer chemotherapy drug, Cisplatin is worth. TLT should be at least that amount until the clinical trials are done...
GL!
Best number I found was for 1997/1998 revenue specifcally was 24M. It surely went up since then but generics came in eventually too as the patent ran out in 2007. From what I can gather it was around $150 million over 30 years. Remember this is just a patent royalty,,, not owner of the treatment and drug sales. Carboplatin patented in 1989, a related drug, earns nearly six times more money in royalties than cisplatin.
https://chem.libretexts.org/Exemplars_and_Case_Studies/ChemCases/Cisplatin%3A_The_Invention_of_an_Anticancer_Drug/Cisplatin_x16._Profits_from_Cisplatin
I guess we'd have to look closer at the revenue of Platinol and Paraplatin to speculate what revenue could look like for a tld treatment. Or indication specific revenues or chemo market as a whole and where tld1433 fits in.
https://chemoth.com/economics
22% of all cancer claims use chemotherapy drugs
Even if TLT can displace a few of them,,, the revenue possibilities are there.. if the science continues, it's pretty easy to see this 60mil market cap left in the dust.
https://chem.libretexts.org/Exemplars_and_Case_Studies/ChemCases/Cisplatin%3A_The_Invention_of_an_Anticancer_Drug/Cisplatin_x16._Profits_from_Cisplatin